Changing trends in the incidence and spectrum of cancers between 1990 and 2021 among HIV-infected patients in Busan, Korea
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- SCIEScopus
- 저널 순위
- JCR Q3Scopus Q2
- 저널
- JOURNAL OF INFECTION AND CHEMOTHERAPY29(6) · pp.571 · 2023
- 피인용
- Web of Science 6Scopus 5
- FWCI (Scopus)
- 0.56
- JCR IF
- JCR 2022 2.2
- ISSN
- 1341-321X
저자
- 이순옥제1저자Pusan Natl Univ, Pusan Natl Univ Hosp, Div Infect Dis, Dept Internal Med,Sch Med, Pusan, South Korea
- 이정은Pusan Natl Univ, Pusan Natl Univ Hosp, Div Infect Dis, Dept Internal Med,Sch Med, Pusan, South Korea
- 심용기Pusan Natl Univ, Pusan Natl Univ Hosp, Div Infect Dis, Dept Internal Med,Sch Med, Pusan, South Korea
- 이신원Pusan Natl Univ, Pusan Natl Univ Hosp, Div Infect Dis, Dept Internal Med,Sch Med, Pusan, South Korea
- 고우석Pusan Natl Univ Hosp, Dept Internal Med, Pusan, South Korea
- 김진미Pusan Natl Univ Hosp, Biomed Inst, Dept Stat, Pusan, South Korea
- 강진숙Inje Univ, Dept Internal Med, Div Infect Dis, Coll Med, Pusan, South Korea
- Son, HyunjinDong A Univ, Donga Univ Hosp, Dept Prevent Med, Sch Med, Pusan, South Korea
- 이선희교신저자Pusan Natl Univ, Pusan Natl Univ Hosp, Div Infect Dis, Dept Internal Med,Sch Med, Pusan, South Korea
초록
Background: Long-term follow-up data on cancer incidence and spectrum among human immunodeficiency virus (HIV)-infected individuals in Korea have been scarce. Material and Methods: This retrospective cohort study included HIV-infected individuals visiting a tertiary care hospital in Busan, South Korea between 1990 and 2021. The observation was divided into 4 periods. The incidence rate was calculated using direct standardization on age and sex, stratified by calendar period. Results: Of the 1,297 patients, 92 patients (7.1%) were diagnosed with 97 cancers. Excluding 37 patients with prevalent cancer, 1,260 patients were followed for a total of 8,803.7 person-years (PYs), and 55 patients developed 60 incident cancers including 5 second primary incident cancers. In men, the AIDS-defining cancer (ADC) incidence decreased from 294.7 per 100,000 PYs in 1990–1997 to 124.8 per 100,000 PYs in 2014–2021, while the non-AIDS-defining cancer (NADC) incidence increased from 0 per 100,000 PYs to 316.5 per 100,000 PYs during the same period. The proportion of virus-unrelated NADCs (VU-NADCs) increased from 33.3% in 1998–2005 to 49% in 2014–2021. The proportion of human papillomavirus-associated cancers (HPVACs) has recently increased in both ADCs and NADCs. The median time from HIV diagnosis to their first cancer was 1.48 years for ADCs, 6.11 years for VR-NADCs, 8.3 years for VU-NADCs, and 11.5 years for HPVACs. Conclusion: The incidence of NADCs is increasing with the aging of HIV-infected patients, and thus, it is necessary to promote cancer screening and prevention programs.
키워드
CancerEpidemiologyHIVHUMAN-IMMUNODEFICIENCY-VIRUSAIDS-DEFINING CANCERSPOPULATIONRISKERA
식별자
- Scopus EID
- 2-s2.0-85150338462
- WoS UID
- 001054050200001



로그인
연구물 목록으로